TRGP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
TRGP is a good buy right now for a beginner with a long-term horizon and $50,000-$100,000 to invest. The stock has strong Wall Street support, positive fundamental commentary from analysts, and no adverse news or insider/congress selling signals. At the current price, it is still near actionable support/resistance territory and the broader setup favors accumulation rather than waiting for a perfect pullback. Given the investor's impatience and long-term goal, I would buy now.
TRGP is in a constructive but not overheated trend. Price is 272.18, above the pivot at 264.47 and just under R1 at 273.367, showing the stock is pressing into resistance rather than breaking down. RSI_6 at 59.01 is neutral-to-bullish, while the MACD histogram is slightly negative and contracting, which suggests short-term momentum has cooled but is not decisively bearish. Converging moving averages point to a potential continuation phase rather than a strong trend reversal. Overall, the technical picture is stable to mildly bullish for a long-term entry.
["Multiple recent analyst price target raises from Citi, Mizuho, BofA, Barclays, Morgan Stanley, RBC, Truist, Scotiabank, TD Cowen, and Stifel.", "Analysts cite marketing and export upside, improved commodity outlook, and peer-leading volume growth.", "Company is viewed as well positioned for growth into 2026 and beyond.", "No negative news in the recent week.", "No recent insider selling trend and no recent congress trading data.", "Options positioning is strongly bullish with low put-call ratios."]
["Short-term technical momentum is slightly soft, with MACD histogram below zero.", "Price is approaching near-term resistance around 273.37 and 278.86.", "Hedge funds and insiders are neutral, with no strong accumulation trend reported.", "No fresh news catalyst in the last week, so near-term upside may rely on continued analyst/fundamental optimism."]
Latest quarter financial details were not available due to a data error, so there is no usable revenue or earnings breakdown here. However, analyst commentary indicates Q1 results were broadly better than anticipated, and several firms raised EBITDA estimates and guidance assumptions. Based on the provided notes, the latest quarter season appears to have shown better-than-expected operating performance and improving growth expectations.
The analyst trend is clearly positive. Recent notes show widespread bullish revisions, with price targets raised into the $257-$331 range and mostly Buy/Outperform ratings. Citi, Mizuho, BofA, RBC, Truist, Scotiabank, and Stifel are constructive, while TD Cowen is the only more cautious voice with a Hold. The Wall Street pros view is net bullish: they like Targa's execution, exposure to Permian activity, marketing upside, and growth projects. The main con is that the stock is already well-followed and near near-term resistance, so upside may be more gradual than explosive.
